The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...

It all started, Tucker Carlson told me, with a “boner joke.” In October 2023, the former Fox News host sat down with the internet comedian Theo Von in a Las Vegas hotel room to record an episode of ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

packaging and shipping of investigational medicines and the factors that should be considered in drawing up a safety monitoring plan. The FDA first issued guidance on DCTs in 2020, out of ...

He was also involved in the creation of the FDA's Digital Health Center of Excellence in 2020 and drawing up the Center for Devices and Radiological Health (CDRH) 2022-2025 strategic priorities ...

All the latest news as Pep Guardiola speaks to the media before Manchester City's Champions League play-off match against ...

The Boston Globe reports that the layoff is the largest in the organization’s history and comes amid financial shortfalls and operational challenges. Also in industry and pharma news: the nurse strike ...

She left the agency saying politics had slowed the approval of the morning-after pill for over-the-counter use. Her resignation drew national attention. By Trip Gabriel Susan F. Wood, a women’s ...

The data that resulted in the FDA approval for zenocutuzumab with NRG1 fusions came from an international clinical trial led by Dr. Schram, called the eNRGy study. Data from 158 patients were included ...

Kevin Walters has found a new job following his departure from the Broncos with the former Brisbane coach signing a deal with Fox Sports.

The draw is finished. Select Play to watch it back.